Degradation of cytochrome P450 2E1: Selective loss after labilization of the enzyme

https://doi.org/10.1016/0003-9861(92)90358-4Get rights and content

Abstract

Mechanism-based inactivation of cytochrome P450 can result in the chemical modification of the heme, the protein, or both as a result of covalent binding of modified heme to the protein. In the present study we took advantage of different modes of inactivation of P450 2E1 by CCl4, 1-aminobenzotriazole, or 3-amino-1,2,4-triazole to investigate parameters which target P450 2E1 for proteolysis from the microsomal membrane. Treatment of mice with CCl4 at the point of maximal induction of P450 2E1 after a single oral dose of acetone resulted in the complete loss of P450 2E1-dependent p-nitrophenol hydroxylation and a 75% loss of immunochemically detectable protein within 1 h of administration. Treatment with 1-aminobenzotriazole at the point of maximal induction caused a complete loss of P450 2E1-dependent p-nitrophenol hydroxylation but only a 12% loss of immunochemically detectable protein 1 h after administration. Treatment of mice with 3-amino-1,2,4-triazole caused a rapid loss of both catalytic activity and microsomal p-nitrophenol hydroxylase activity. However, unlike CCl4 treatment, the activity and enzyme level rebounded 5 and 9 h after treatment. The P450 2E1 ligand, 4-methylpyrazole, administered at the point of maximal induction maintained the acetone-induced catalytic and immunochemical level of P450 2E1. These results suggest that differentially modified forms of P450 2E1 show a characteristic susceptibility to degradation. While there are many potential pathways for protein degradation, the loss of P450 2E1 was associated with increased formation of hieh molecular weight microsomal ubiquitin conjugates. The formation of ubiquitin-conjugated microsomal protein which correlates with P450 2E1 loss suggests that ubiquitination may represent a proteolytic signal for the rapid and selective proteolysis of certain labilized conformations of P450 2E1 from the endoplasmic reticulum.

References (58)

  • F.P. Guengerich

    J. Biol. Chem

    (1991)
  • A. Parkinson et al.

    Arch. Biochem. Biophys

    (1983)
  • H. Shiraki et al.

    Arch. Biochem. Biophys

    (1984)
  • J.F. Hare

    Biochim. Biophys. Acta

    (1990)
  • R.D. Klausner et al.

    Cell

    (1990)
  • B. Song et al.

    J. Biol. Chem

    (1989)
  • A.L. Haas et al.

    J. Biol. Chem

    (1985)
  • M.J. Coon et al.
  • A.H. Phillips et al.

    J. Biol. Chem

    (1962)
  • T. Omura et al.

    J. Biol. Chem

    (1964)
  • D.R. Koop et al.

    J. Biol. Chem

    (1981)
  • P. Strittmatter et al.
  • D.R. Koop et al.

    Arch. Biochem. Biophys

    (1984)
  • H.W. Davies et al.

    Arch. Biochem. Biophys

    (1986)
  • Y. Osawa et al.

    J. Biol. Chem

    (1990)
  • I. Johansson et al.

    FEBS Lett

    (1985)
  • B. Head et al.

    Toxicol. Appl. Pharmacol

    (1981)
  • T. Noguchi et al.

    Biochem. Pharmacol

    (1982)
  • R. Hough et al.

    Biol. Chem

    (1986)
  • L. Gregori et al.

    J. Biol. Chem

    (1985)
  • R.T. Schimke

    Curr. Top. Cell Regul

    (1969)
  • A. Hershko

    J. Biol. Chem

    (1988)
  • K.J.A. Davies

    J. Biol. Chem

    (1987)
  • D.C. Salo et al.

    J. Biol. Chem

    (1990)
  • P.B. Watkins et al.

    J. Biol. Chem

    (1986)
  • M.A. Correia et al.

    Arch. Biochem. Biophys

    (1987)
  • F.J. Gonzalez

    Pharmacol. Rev

    (1989)
  • D.W. Nebert et al.

    DNA Cell Biol

    (1991)
  • C.D. Campbell et al.

    J. Chem. Soc. C

    (1969)
  • Cited by (0)

    This work was supported by Grant AA-08608 from the National Institute on Alcohol Abuse and Alcoholism (D.R.K.) and Grant GM-34009 from the National Institutes of Health (A.L.H.).

    View full text